For instance, studies have demonstrated that blocking pro-inflammatory cytokines like IL-7 or administering anti-TNF antibodies can restore AQP5 levels and improve symptoms in SS models, suggesting a strong connection between inflammation and AQP5 dysregulation (80, 81). The gene discussed is AQP5; the disease is synovial sarcoma.